Inactive Instrument

Highlights Immune Therapeutics, Inc. Other OTC

Equities

IMUN

US45252A1079

Highlights

Unlock all the news: Be the first to know and act before the market!

Biostax Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20	CI
Biostax Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Biostax Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV	23-08-29	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
Immune Therapeutics, Inc. Announces the Fdas Acceptance of Three Investigational New Drug Applications Transfers for Jkb-122 for the Treatment of Nash, Nafld and Aih	23-08-15	CI
Immune Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-10	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-24	CI
Immune Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-03	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Immune Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-15	CI
Immune Therapeutics Inc. Spinoff Cytocom, Inc. to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During “J.P. Morgan Week 2021”	21-01-11	GL
Immune Therapeutics, Inc. cancelled the acquisition of Aletheia Therapeutics, Inc..	20-12-15	CI
Immune Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
Immune Therapeutics : Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs	20-10-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Immune Therapeutics, Inc. Other OTC

Equities

IMUN

US45252A1079

Highlights

Filters